Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients

NCT00684632 is registered in ClinicalTrials.gov with Kyowa Kirin Co., Ltd. as lead sponsor.

NCT NCT00684632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00684632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients
Lead sponsor
Kyowa Kirin Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2008
Completion date
April 30, 2009
Enrollment
51 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

pain, cancer